Two ladies with bruises

doi:10.1017/9781108623872.023

Case 23: - Two ladies with bruises

Published online by Cambridge University Press: 03 April 2024

Nevena Radonjić

Edited by

Nevena V. Radonjić ,

Thomas L. Schwartz and

Stephen M. Stahl

Show author details

Nevena V. Radonjić: Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz: Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl: Affiliation:
University of California, San Diego

Book contents

Get access

Summary

Selective serotonin reuptake inhibitors (SSRIs) mainly affect the platelets by which of the following?

Keywords

serotonin platelets bleeding non-steroid anti-inflammatory drugs (NSAIDs)citalopram (Celexa)duloxetine (Cymbalta)ibuprofen (Advil)

Type: Chapter
Information: Case Studies: Stahl's Essential Psychopharmacology , pp. 395 - 402

DOI: https://doi.org/10.1017/9781108623872.023 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Subscription

Individual access

Subscriptions are only available for individuals and not institutional access. Subscribe now

References

Andrade, C. Selective serotonin reuptake inhibitor use in pregnancy and risk of postpartum hemorrhage. J Clin Psychiatry 2022; 83(2):22f14455CrossRef Google Scholar PubMed

Anglin, R, Yuan, Y, Moayyedi, P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 811–19CrossRef Google Scholar PubMed

Brazell, C, McClue, SJ, Preston, GC, et al. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors. Blood Coagul Fibrinolysis 1991; 2:17–24CrossRef Google Scholar

Dalton, SO, Johansen, C, Mellemkjaer, L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163:59–64CrossRef Google Scholar PubMed

Halperin, D, Reber, G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007; 9:47–59CrossRef Google Scholar PubMed

Jiang, HY, Chen, HZ, Hu, XJ, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13:42–50.e43CrossRef Google Scholar PubMed

Maclean, JA, Schoenwaelder, SM. Serotonin in platelets. In Pilowsky, M, ed., Serotonin: The Mediator that Spans Evolution. Boston: Academic Press, 2019, 91–119CrossRef Google Scholar

McCloskey, DJ, Postolache, TT, Vittone, BJ, et al. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res 2008; 151:168–72CrossRef Google Scholar PubMed

Meijer, WEE, Heerdink, ER, Nolen, WA, et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004; 164:2367–70CrossRef Google Scholar PubMed

Nochaiwong, S, Ruengorn, C, Awiphan, R, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med 2022; 54:80–97CrossRef Google Scholar PubMed

Perahia, DG, Bangs, ME, Zhang, Q, et al. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthc Patient Saf 2013; 5:211–19Google Scholar PubMed

Quinn, GR, Hellkamp, AS, Hankey, GJ, et al. Selective serotonin reuptake inhibitors and bleeding risk in anticoagulated patients with atrial fibrillation: an analysis from the ROCKET AF Trial. J Am Heart Assoc 2018; 7:e008755CrossRef Google Scholar PubMed

Renoux, C, Vahey, S, Dell’Aniello, S, et al. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurology 2017; 74:173–80Google Scholar PubMed

Rudnick, G. SERT, Serotonin Transporter. New York: Elsevier, 2007CrossRef Google Scholar

Samuel, NG, Seifert, CF. Risk of bleeding in patients on full-dose enoxaparin with venous thromboembolism and selective serotonin reuptake inhibitors. Ann Pharmacother 2017; 51:226–31CrossRef Google Scholar PubMed

Song, HR, Jung, Y-E, Wang, H-R, et al. Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients. Psychiatry Clin Neurosci 2012; 66:457–9CrossRef Google Scholar PubMed